MICROCHIP TECHNOLOGY INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that MICROCHIP TECHNOLOGY INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Mar 31, 2019 | $1.33B | May 30, 2019 |
| FY2019 | Dec 31, 2018 | $1.37B | May 30, 2019 |
| FY2019 | Sep 30, 2018 | $1.43B | May 30, 2019 |
| FY2019 | Jun 30, 2018 | $1.21B | May 30, 2019 |
| FY2019 | Mar 31, 2018 | $1.00B | May 30, 2019 |
| FY2019 | Dec 31, 2017 | $994.20M | May 30, 2019 |
| FY2019 | Sep 30, 2017 | $1.01B | May 30, 2019 |
| FY2019 | Jun 30, 2017 | $972.10M | May 30, 2019 |
| FY2019 | Mar 31, 2017 | $3.41B | May 30, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $4.40B | May 23, 2025 |
| FY2025 | Mar 31, 2024 | $7.63B | May 23, 2025 |
| FY2025 | Mar 31, 2023 | $8.44B | May 23, 2025 |
| FY2024 | Mar 31, 2022 | $6.82B | May 23, 2024 |
| FY2023 | Mar 31, 2021 | $5.44B | May 25, 2023 |
| FY2020 | Mar 31, 2020 | $1.33B | May 22, 2020 |
| FY2020 | Dec 31, 2019 | $1.29B | May 22, 2020 |
| FY2020 | Sep 30, 2019 | $1.34B | May 22, 2020 |
| FY2020 | Jun 30, 2019 | $1.32B | May 22, 2020 |
| FY2020 | Mar 31, 2019 | $1.33B | May 22, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Mar 31, 2018 | $1.00B | May 18, 2018 |
| FY2018 | Dec 31, 2017 | $994.20M | May 18, 2018 |
| FY2018 | Sep 30, 2017 | $1.01B | May 18, 2018 |
| FY2018 | Jun 30, 2017 | $972.10M | May 18, 2018 |
| FY2018 | Mar 31, 2017 | $902.70M | May 18, 2018 |
| FY2018 | Dec 31, 2016 | $834.40M | May 18, 2018 |
| FY2018 | Sep 30, 2016 | $871.40M | May 18, 2018 |
| FY2018 | Jun 30, 2016 | $799.40M | May 18, 2018 |
| FY2017 | Mar 31, 2016 | $557.65M | May 30, 2017 |
| FY2017 | Dec 31, 2015 | $540.34M | May 30, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $2.47B | May 23, 2025 |
| FY2025 | Mar 31, 2024 | $5.00B | May 23, 2025 |
| FY2025 | Mar 31, 2023 | $5.70B | May 23, 2025 |
| FY2024 | Mar 31, 2022 | $4.45B | May 23, 2024 |
| FY2023 | Mar 31, 2021 | $3.38B | May 25, 2023 |
| FY2020 | Mar 31, 2020 | $813.90M | May 22, 2020 |
| FY2020 | Dec 31, 2019 | $785.50M | May 22, 2020 |
| FY2020 | Sep 30, 2019 | $827.50M | May 22, 2020 |
| FY2020 | Jun 30, 2019 | $815.20M | May 22, 2020 |
| FY2020 | Mar 31, 2019 | $820.50M | May 22, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($500.0K) | May 23, 2025 |
| FY2025 | Mar 31, 2024 | $1.91B | May 23, 2025 |
| FY2025 | Mar 31, 2023 | $2.24B | May 23, 2025 |
| FY2024 | Mar 31, 2022 | $1.29B | May 23, 2024 |
| FY2023 | Mar 31, 2021 | $349.40M | May 25, 2023 |
| FY2020 | Mar 31, 2020 | $99.90M | May 22, 2020 |
| FY2020 | Dec 31, 2019 | $311.10M | May 22, 2020 |
| FY2020 | Sep 30, 2019 | $108.90M | May 22, 2020 |
| FY2020 | Jun 30, 2019 | $50.70M | May 22, 2020 |
| FY2020 | Mar 31, 2019 | $174.70M | May 22, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $296.30M | May 23, 2025 |
| FY2025 | Mar 31, 2024 | $2.57B | May 23, 2025 |
| FY2025 | Mar 31, 2023 | $3.12B | May 23, 2025 |
| FY2024 | Mar 31, 2022 | $1.85B | May 23, 2024 |
| FY2023 | Mar 31, 2021 | $998.10M | May 25, 2023 |
| FY2020 | Mar 31, 2020 | $160.70M | May 22, 2020 |
| FY2020 | Dec 31, 2019 | $131.20M | May 22, 2020 |
| FY2020 | Sep 30, 2019 | $183.60M | May 22, 2020 |
| FY2020 | Jun 30, 2019 | $171.60M | May 22, 2020 |
| FY2020 | Mar 31, 2019 | $284.60M | May 22, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $983.80M | May 23, 2025 |
| FY2025 | Mar 31, 2024 | $1.10B | May 23, 2025 |
| FY2025 | Mar 31, 2023 | $1.12B | May 23, 2025 |
| FY2024 | Mar 31, 2022 | $989.10M | May 23, 2024 |
| FY2023 | Mar 31, 2021 | $836.40M | May 25, 2023 |
| FY2022 | Mar 31, 2020 | $877.80M | May 20, 2022 |
| FY2021 | Mar 31, 2019 | $826.30M | May 18, 2021 |
| FY2020 | Mar 31, 2018 | $529.30M | May 22, 2020 |
| FY2019 | Mar 31, 2017 | $545.30M | May 30, 2019 |
| FY2018 | Mar 31, 2016 | $372.60M | May 18, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $617.70M | May 23, 2025 |
| FY2025 | Mar 31, 2024 | $734.20M | May 23, 2025 |
| FY2025 | Mar 31, 2023 | $797.70M | May 23, 2025 |
| FY2024 | Mar 31, 2022 | $718.90M | May 23, 2024 |
| FY2023 | Mar 31, 2021 | $610.30M | May 25, 2023 |
| FY2022 | Mar 31, 2020 | $676.60M | May 20, 2022 |
| FY2021 | Mar 31, 2019 | $682.90M | May 18, 2021 |
| FY2020 | Mar 31, 2018 | $452.10M | May 22, 2020 |
| FY2019 | Mar 31, 2017 | $499.80M | May 30, 2019 |
| FY2018 | Mar 31, 2016 | $301.70M | May 18, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $898.10M | May 23, 2025 |
| FY2025 | Mar 31, 2024 | $2.89B | May 23, 2025 |
| FY2025 | Mar 31, 2023 | $3.62B | May 23, 2025 |
| FY2024 | Mar 31, 2022 | $2.84B | May 23, 2024 |
| FY2023 | Mar 31, 2021 | $1.92B | May 25, 2023 |
| FY2022 | Mar 31, 2020 | $1.54B | May 20, 2022 |
| FY2021 | Mar 31, 2019 | $1.67B | May 18, 2021 |
| FY2020 | Mar 31, 2018 | $1.42B | May 22, 2020 |
| FY2013 | Mar 31, 2013 | $459.37M | May 30, 2014 |
| FY2013 | Mar 31, 2012 | $411.98M | May 30, 2014 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $126.00M | May 23, 2025 |
| FY2025 | Mar 31, 2024 | $285.10M | May 23, 2025 |
| FY2025 | Mar 31, 2023 | $486.20M | May 23, 2025 |
| FY2024 | Mar 31, 2022 | $370.10M | May 23, 2024 |
| FY2023 | Mar 31, 2021 | $92.60M | May 25, 2023 |
| FY2022 | Mar 31, 2020 | $67.60M | May 20, 2022 |
| FY2021 | Mar 31, 2019 | $228.90M | May 18, 2021 |
| FY2020 | Mar 31, 2018 | $206.80M | May 22, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $15.37B | May 23, 2025 |
| FY2025 | Mar 31, 2024 | $15.87B | May 23, 2025 |
| FY2024 | Mar 31, 2023 | $16.37B | May 23, 2024 |
| FY2023 | Mar 31, 2022 | $16.20B | May 25, 2023 |
| FY2022 | Mar 31, 2021 | $16.48B | May 20, 2022 |
| FY2021 | Mar 31, 2020 | $17.43B | May 18, 2021 |
| FY2020 | Mar 31, 2019 | $18.35B | May 22, 2020 |
| FY2019 | Mar 31, 2018 | $8.26B | May 30, 2019 |
| FY2018 | Mar 31, 2017 | $7.69B | May 18, 2018 |
| FY2017 | Mar 31, 2016 | $5.54B | May 30, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $7.08B | May 23, 2025 |
| FY2025 | Mar 31, 2024 | $6.66B | May 23, 2025 |
| FY2025 | Mar 31, 2023 | $6.51B | May 23, 2025 |
| FY2025 | Mar 31, 2022 | $5.89B | May 23, 2025 |
| FY2024 | Mar 31, 2021 | $5.34B | May 23, 2024 |
| FY2023 | Mar 31, 2020 | $5.59B | May 25, 2023 |
| FY2022 | Mar 31, 2019 | $5.29B | May 20, 2022 |
| FY2021 | Mar 31, 2018 | $3.28B | May 18, 2021 |
| FY2020 | Mar 31, 2017 | $3.27B | May 22, 2020 |
| FY2017 | Mar 31, 2016 | ($3.36M) | May 30, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $6.68B | May 23, 2025 |
| FY2025 | Mar 31, 2024 | $6.68B | May 23, 2025 |
| FY2024 | Mar 31, 2023 | $6.67B | May 23, 2024 |
| FY2023 | Mar 31, 2022 | $6.67B | May 25, 2023 |
| FY2022 | Mar 31, 2021 | $6.67B | May 20, 2022 |
| FY2021 | Mar 31, 2020 | $6.66B | May 18, 2021 |
| FY2020 | Mar 31, 2019 | $6.66B | May 22, 2020 |
| FY2019 | Mar 31, 2018 | $2.30B | May 30, 2019 |
| FY2018 | Mar 31, 2017 | $2.30B | May 18, 2018 |
| FY2017 | Mar 31, 2016 | $1.01B | May 30, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $5.78B | May 23, 2025 |
| FY2025 | Mar 31, 2024 | $6.76B | May 23, 2025 |
| FY2024 | Mar 31, 2023 | $5.76B | May 23, 2024 |
| FY2023 | Mar 31, 2022 | $4.18B | May 25, 2023 |
| FY2022 | Mar 31, 2021 | $3.39B | May 20, 2022 |
| FY2021 | Mar 31, 2020 | $3.43B | May 18, 2021 |
| FY2020 | Mar 31, 2019 | $3.21B | May 22, 2020 |
| FY2019 | Apr 1, 2018 | $3.20B | May 30, 2019 |
| FY2019 | Mar 31, 2018 | $1.40B | May 30, 2019 |
| FY2018 | Mar 31, 2017 | $1.48B | May 18, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $771.70M | May 23, 2025 |
| FY2025 | Mar 31, 2024 | $319.70M | May 23, 2025 |
| FY2024 | Mar 31, 2023 | $234.00M | May 23, 2024 |
| FY2023 | Mar 31, 2022 | $317.40M | May 25, 2023 |
| FY2022 | Mar 31, 2021 | $280.00M | May 20, 2022 |
| FY2021 | Mar 31, 2020 | $401.00M | May 18, 2021 |
| FY2020 | Mar 31, 2019 | $428.60M | May 22, 2020 |
| FY2019 | Mar 31, 2018 | $901.30M | May 30, 2019 |
| FY2018 | Mar 31, 2017 | $908.70M | May 18, 2018 |
| FY2018 | Mar 31, 2016 | $2.09B | May 18, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $5.63B | May 23, 2025 |
| FY2025 | Mar 31, 2024 | $6.00B | May 23, 2025 |
| FY2024 | Mar 31, 2023 | $6.44B | May 23, 2024 |
| FY2023 | Mar 31, 2022 | $7.69B | May 25, 2023 |
| FY2022 | Mar 31, 2021 | $8.90B | May 20, 2022 |
| FY2021 | Mar 31, 2020 | $9.48B | May 18, 2021 |
| FY2020 | Mar 31, 2019 | $10.31B | May 22, 2020 |
| FY2019 | Mar 31, 2018 | $3.07B | May 30, 2019 |
| FY2018 | Mar 31, 2017 | $2.95B | May 18, 2018 |
| FY2017 | Mar 31, 2016 | $2.45B | May 30, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | May 23, 2025 |
| FY2025 | Mar 31, 2024 | 3 | May 23, 2025 |
| FY2025 | Mar 31, 2023 | 4 | May 23, 2025 |
| FY2024 | Mar 31, 2022 | 2 | May 23, 2024 |
| FY2023 | Mar 31, 2021 | 0 | May 25, 2023 |
| FY2022 | Mar 31, 2020 | 1 | May 20, 2022 |
| FY2021 | Mar 31, 2019 | 1 | May 18, 2021 |
| FY2020 | Mar 31, 2018 | 1 | May 22, 2020 |
| FY2019 | Mar 31, 2017 | 0 | May 30, 2019 |
| FY2018 | Mar 31, 2016 | 1 | May 18, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | May 23, 2025 |
| FY2025 | Mar 31, 2024 | 3 | May 23, 2025 |
| FY2025 | Mar 31, 2023 | 4 | May 23, 2025 |
| FY2024 | Mar 31, 2022 | 2 | May 23, 2024 |
| FY2023 | Mar 31, 2021 | 0 | May 25, 2023 |
| FY2020 | Mar 31, 2020 | 0 | May 22, 2020 |
| FY2020 | Dec 31, 2019 | 1 | May 22, 2020 |
| FY2020 | Sep 30, 2019 | 0 | May 22, 2020 |
| FY2020 | Jun 30, 2019 | 0 | May 22, 2020 |
| FY2020 | Mar 31, 2019 | 0 | May 22, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 538.70M | May 23, 2025 |
| FY2025 | Mar 31, 2024 | 536.66M | May 23, 2025 |
| FY2024 | Mar 31, 2023 | 545.46M | May 23, 2024 |
| FY2023 | Mar 31, 2022 | 554.50M | May 25, 2023 |
| FY2022 | Mar 31, 2021 | 547.06M | May 20, 2022 |
| FY2021 | Mar 31, 2020 | 245.33M | May 18, 2021 |
| FY2020 | Mar 31, 2019 | 237.59M | May 22, 2020 |
| FY2019 | Mar 31, 2018 | 235.03M | May 30, 2019 |
| FY2018 | Mar 31, 2017 | 229.09M | May 18, 2018 |
| FY2017 | Mar 31, 2016 | 204.08M | May 30, 2017 |